[Late phase II study of S-1 in patients with advanced head and neck cancer].
about
Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: phase I trial.Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer.Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck.Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancerPhase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706).Effects of a concurrent chemoradiotherapy with S-1 for locally advanced oral cancer.Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma.A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)Phase II study of S-1 in patients with advanced biliary tract cancer.Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer.Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer.Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas.Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo.
P2860
Q33366682-B5648809-ACE0-4BA1-9436-33BA2DDC7743Q33420293-3B19AD95-4ED0-470E-9FD0-34A96169996CQ33842362-054C2858-C053-4637-9FA1-602963AEB386Q33884698-A5EC2C8E-E22F-45BC-AF5E-647D7718DA44Q34623415-4C9CC221-942C-490C-A05E-E31A8B6EDA6EQ34733346-8BBE1FDA-CAB8-4461-9092-6979376A6462Q35004744-CFB958AE-EA68-4DD6-81F2-37FD5106E062Q35754239-A132E9C1-19B3-4967-B81C-6EC34808CB99Q36126517-010EAB74-63E5-452E-A48B-BAE76D7C9747Q36403236-A7D689BF-8936-48C3-9228-01C56E37E0BFQ36609407-66ED2DBD-25D2-4847-90D0-B55C9448688AQ36615451-C301FB2C-CC9F-4EA9-B6AD-7BD3E16EB713Q36694425-48238147-7B1F-4266-A3D5-9ED0D8C25754Q36696249-5B45672A-FF53-4887-8007-9C153AA6844BQ36714999-078E1EB4-8A89-4380-8A5A-6588853A2E91Q37006925-CD7D446D-031F-44A5-B052-A50280A93D7AQ37252364-A5428852-C885-4D61-8EDA-28886C727AC1Q37308769-7257DF27-D3D4-4D6B-A4B0-965920E24080Q40022137-9B3866E0-B785-41DD-97E3-2614D5B8AC9BQ41619182-EC08E817-7AAE-4608-B0AA-3B700D2467B4
P2860
[Late phase II study of S-1 in patients with advanced head and neck cancer].
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@ast
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@en
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@nl
type
label
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@ast
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@en
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@nl
prefLabel
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@ast
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@en
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@nl
P2093
P1476
[Late phase II study of S-1 in patients with advanced head and neck cancer].
@en
P2093
S-1 Cooperative Study Group (Head and Neck Cancer Working Group)
P304
P407
P577
2001-10-01T00:00:00Z